Showing results (461-470 of 475) with videos related to
Sort By:
Pageof 48
Nature Genetics|March 3, 2015
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissueColin S Cooper, Rosalind Eeles, David C Wedge, et al.Nature|June 23, 2012
The landscape of cancer genes and mutational processes in breast cancerPhilip J Stephens, Patrick S Tarpey, Helen Davies, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumToji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, et al.Regulatory Toxicology and Pharmacology : RTP|June 14, 2019
Genetic toxicology in silico protocolCatrin Hasselgren, Ernst Ahlberg, Yumi Akahori, et al.Nature Genetics|April 21, 2009
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardationPatrick S Tarpey, Raffaella Smith, Erin Pleasance, et al.Nature|July 11, 2018
Prediction of acute myeloid leukaemia risk in healthy individualsSagi Abelson, Grace Collord, Stanley W K Ng, et al.Nature|August 16, 2013
Signatures of mutational processes in human cancerLudmil B Alexandrov, Serena Nik-Zainal, David C Wedge, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2019
Nonlinear Z-score modeling for improved detection of cognitive abnormalityJohn Kornak, Julie Fields, Walter Kremers, et al.Nature|May 1, 2024
Geographic variation of mutagenic exposures in kidney cancer genomesSergey Senkin, Sarah Moody, Marcos Díaz-Gay, et al.Nature Genetics|April 18, 2018
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targetsDavid C Wedge, Gunes Gundem, Thomas Mitchell, et al.Pageof 48